A year of themes
In 2024, Indian fund houses launched 70 new equity funds other than index funds. Fifty-three of them, 76%, were sector or thematic funds, spread across 29 fund houses. This looks at how those 53 stand now, on NAVs of 7 October 2026, Direct plan, Growth option.
New fund offers are normally priced at ₹10 a unit, so a NAV under ₹10 means the fund is below where it started and a NAV over ₹10 means it has gained. That is a plain test, but it tells you something the one-year return does not.
Where the NAVs stand
| NAV band | Funds | Share |
|---|---|---|
| Below ₹10 (under the launch price) | 14 | 26.4% |
| ₹10 to ₹12 | 25 | 47.2% |
| ₹12 and above | 14 | 26.4% |
| All | 53 |
The median NAV is ₹10.85: a gain of about 8.5% on the launch price after between 21 and 33 months, depending on the fund. The lowest is ₹7.89 and the highest ₹17.24.
Later launches fared worse
The year's launches were not spread evenly. They bunched at the end:
| Launch quarter of 2024 | Funds | Below ₹10 | Median one-year return |
|---|---|---|---|
| Jan–Mar | 11 | 0 | +2.79% |
| Apr–Jun | 9 | 2 | +6.10% |
| Jul–Sep | 13 | 5 | +3.81% |
| Oct–Dec | 20 | 7 | −2.08% |
Twenty of the 53, 38%, launched in the last three months of 2024, the most of any quarter. Seven of those are now under ₹10 and the group's median one-year return is negative. None of the 11 January–March funds is below ₹10.
The data shows only that later launches did worse in this stretch. It does not show why, and a fund's starting date is one of several things that separate them.
Against the older themes
Sector and thematic funds that existed before 2024 have a median one-year return of 0.74% across 149 funds, below the 2024 class's 1.64%. The share losing money over a year is 43.0% for the older ones and 37.7% for the new ones.
So the newer funds are not, as a group, worse than the older ones over the past year. The older funds' longer record shows in the other direction, though: only one of the 152 older funds has a NAV under ₹10, since their NAVs have had many more years to grow.
Who is at the top and bottom
One-year returns to 7 October 2026 for the best and worst of the 2024 class:
| Fund | One-year return | NAV |
|---|---|---|
| PGIM India Healthcare Fund | +23.2% | ₹12.20 |
| WhiteOak Capital Pharma and Healthcare Fund | +20.9% | ₹17.24 |
| HSBC India Export Opportunities Fund | +20.1% | ₹11.90 |
| Union Active Momentum Fund | +19.3% | ₹10.40 |
| ... | ||
| SBI Quant Fund | −7.2% | ₹9.04 |
| Kotak Technology Fund | −8.7% | ₹10.45 |
| Axis Consumption Fund | −9.1% | ₹8.97 |
Healthcare and pharma funds fill two of the top three places, and the spread from top to bottom is more than 32 points. For how existing healthcare funds have returned, see pharma and healthcare fund returns. The wider risk and reward of sectoral funds covers the category as a whole.
What this does not tell you
A NAV under ₹10 is not a measure of skill. It depends on when you buy: someone who put money in a fund after it fell to ₹9 would be ahead of its launch-day investor.
Short records are noisy. None of these funds has run for three years, and a theme's results over 12 months say little about the next 12.
The sample is one year's launches. Funds that were closed or merged within the period, if any, are not in the count.
This is not a recommendation for or against any fund or theme.
Frequently asked questions
How many thematic funds launched in 2024 are below their launch price?
Of 53 sector and thematic funds that began in 2024 (Direct plan, Growth option), 14 had a NAV below ₹10 on 7 October 2026, the usual launch price. 25 sit between ₹10 and ₹12 and 14 are at ₹12 or above. The median NAV is ₹10.85.
Did thematic funds launched in 2024 beat older thematic funds?
Over the last year, narrowly. The 2024 class had a median one-year return of 1.64%, against 0.74% for 152 thematic funds that were launched before 2024. 20 of the 53 newer funds lost money over the year, 37.7%, against 64 of 149 older ones, 43.0%.
Which 2024 launches did best and worst?
Over one year to 7 October 2026 the best were PGIM India Healthcare (+23.2%), WhiteOak Capital Pharma and Healthcare (+20.9%) and HSBC India Export Opportunities (+20.1%). The weakest were Axis Consumption (−9.1%), Kotak Technology (−8.7%) and SBI Quant (−7.2%).
This is commentary on published data, not investment advice. WealthTicker is not a SEBI-registered adviser or distributor. Figures are WealthTicker’s own calculations from public data — AMFI’s fund NAVs and disclosures, NSE’s index and FII/DII files, and the fund houses’ monthly portfolios (how we calculate). They are as of the dates stated and can be revised by their source.
Keep reading
Sector funds in Q3 2026: technology and pharma led
Of 251 sectoral and thematic funds, 66 gained in the three months to 1 October 2026. Technology funds led (median +3.69%), banking funds trailed (-6.30%).
Sectoral and thematic funds: reward, risk or marketing?
Over three years to October 2026, sector fund returns ran from −4.4% to 36% a year. Pharma funds led at a 20.8% median; technology trailed at 4.9%.
Business cycle funds: all 10 with 3 years beat Nifty 500
19 business cycle funds hold ₹42,278 crore. All 10 with three years beat the Nifty 500 TRI to October 2026, at a median 12.4% a year. Banks lead most of them.
